RDY

Dr. Reddy's Laboratories Limited NYSE Listed Apr 11, 2001

Healthcare ·Drug Manufacturers - Specialty & Generic ·IN · drreddys.com

$13.46

Mkt Cap $11.2B

52w Low $12.77 20.3% of range 52w High $16.17

50d MA $13.75 200d MA $13.98

P/E (TTM) 0.2x

EV/EBITDA 10.1x

P/B 0.0x

Debt/Equity 0.1x

ROE —

P/FCF 78.2x

RSI (14) —

ATR (14) —

Beta 0.30

50d MA $13.75

200d MA $13.98

Avg Volume 2.9M

About

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Jan 20, 2026	AMC	0.16	0.16	+0.0%	12.94	-0.3%	+2.6%	+6.0%	+5.7%	+6.5%	+6.0%	—
Oct 24, 2025	AMC	0.19	0.19	-1.4%	14.58	-0.3%	-0.8%	+0.1%	-8.0%	-7.8%	-8.8%	—
Jul 23, 2025	AMC	0.21	0.20	-6.7%	14.60	+1.0%	+0.8%	+0.5%	+0.7%	+1.1%	-3.4%	—
May 9, 2025	AMC	0.21	0.22	+4.0%	13.40	+2.0%	+4.0%	+5.2%	+5.5%	+7.4%	+7.8%	—
Nov 5, 2024	AMC	0.21	0.04	-80.6%	14.61	+4.7%	+4.0%	+3.3%	+3.4%	+2.7%	+1.1%	—
Jul 27, 2024	AMC	0.19	0.20	+4.0%	—	—	—	—	—	—	—	—
May 8, 2024	AMC	0.86	0.70	-18.6%	14.30	-1.3%	-2.9%	-3.3%	-2.2%	-2.6%	-2.6%	—
Jan 31, 2024	AMC	0.18	0.20	+13.3%	14.39	-0.5%	+0.6%	+0.3%	+1.3%	+1.7%	+2.0%	—
Oct 27, 2023	AMC	0.17	0.21	+20.3%	13.01	-0.3%	-0.5%	+0.2%	+0.7%	-0.8%	-1.2%	—
Jul 26, 2023	AMC	0.15	0.21	+36.4%	13.61	-1.0%	-0.1%	+1.1%	+1.0%	+1.8%	+1.9%	—
May 10, 2023	AMC	0.12	0.14	+21.6%	11.71	-5.2%	-6.5%	-6.9%	-5.6%	-5.8%	-6.7%	—
Jan 25, 2023	AMC	0.14	0.18	+32.4%	10.47	+0.7%	+0.3%	+1.9%	+2.2%	+2.8%	+3.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jun 5	HSBC	Upgrade	Hold → Buy	—	$14.75	$15.34	+4.0%	+5.3%	+5.4%	+6.0%	+7.7%	+8.0%
Nov 6	Barclays	Maintains	Overweight → Overweight	—	$14.61	$15.30	+4.7%	+4.0%	+3.3%	+3.4%	+2.7%	+1.1%
Jul 30	Barclays	Maintains	Overweight → Overweight	—	$16.40	$16.35	-0.3%	-1.6%	-0.9%	+0.7%	+1.5%	-1.5%
May 8	Barclays	Maintains	Overweight → Overweight	—	$14.27	$14.32	+0.4%	+0.2%	-2.7%	-3.1%	-2.0%	-2.4%
Jan 29	Barclays	Maintains	Overweight → Overweight	—	$13.91	$14.15	+1.7%	+0.7%	-0.2%	+3.5%	+4.1%	+3.8%
Jun 1	Barclays	Maintains	Overweight → Overweight	—	$11.04	$11.22	+1.6%	+1.1%	+2.7%	+2.2%	+2.8%	+3.4%
Oct 31	Barclays	Maintains	Overweight → Overweight	—	$11.05	$10.82	-2.1%	-1.7%	+0.9%	+0.2%	+1.1%	+0.7%
Oct 25	Barclays	Maintains	Overweight → Overweight	—	$10.51	$10.64	+1.2%	+1.9%	+2.8%	+3.8%	+5.1%	+3.3%
Sep 12	Barclays	Maintains	Overweight → Overweight	—	$10.69	$10.78	+0.8%	+0.9%	-1.3%	-1.0%	-3.3%	-5.3%
Jul 25	Barclays	Maintains	Overweight → Overweight	—	$11.06	$10.95	-1.0%	-1.9%	-4.3%	-1.6%	-5.3%	-6.9%
May 24	Barclays	Maintains	Overweight → Overweight	—	$11.01	$11.23	+2.0%	+2.6%	+0.7%	+0.4%	+2.3%	+0.5%
Nov 1	Barclays	Maintains	Overweight → Overweight	—	$12.29	$12.69	+3.3%	+3.4%	+3.2%	+4.1%	+3.7%	+3.2%
Feb 2	Barclays	Upgrade	Equal Weight → Overweight	—	$11.83	$12.28	+3.8%	+3.0%	+5.8%	+7.4%	+10.9%	+11.4%
Jan 28	CLSA	Maintains	Buy → Outperform	—	$8.84	$8.77	-0.8%	+0.7%	+0.3%	-0.1%	-1.1%	-0.2%
Jan 9	Citigroup	Upgrade	Sell → Buy	—	$8.18	$8.19	+0.1%	+0.9%	+0.4%	+1.7%	+2.4%	+1.7%
Nov 4	Bank of America	Downgrade	Buy → Neutral	—	$7.97	$7.94	-0.4%	-1.4%	+0.9%	+1.1%	+1.3%	+0.1%
Nov 4	BofA Securities	Downgrade	Buy → Neutral	—	$7.97	$7.94	-0.4%	-1.4%	+0.9%	+1.1%	+1.3%	+0.1%
Sep 4	Credit Suisse	Upgrade	Underperform → Outperform	—	$7.05	$7.17	+1.7%	+4.4%	+6.1%	+8.1%	+9.1%	+9.8%
Jun 11	Barclays	Maintains	Equal Weight → Equal Weight	—	$7.58	$7.64	+0.8%	+0.1%	-0.7%	-2.6%	-2.2%	-4.4%
May 20	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$7.88	$7.39	-6.2%	-6.1%	-3.6%	-3.9%	-4.3%	-3.2%
Nov 1	Jefferies	Maintains	Underperform → Underperform	—	$7.27	$7.17	-1.4%	-1.9%	+3.4%	+1.1%	+1.1%	-1.2%
Sep 21	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$7.14	$7.62	+6.7%	+5.6%	+5.5%	+2.5%	+0.0%	-3.4%
Jul 27	Jefferies	Downgrade	Hold → Underperform	—	$8.82	$8.71	-1.2%	-0.7%	-1.1%	-1.0%	+0.9%	+0.0%
Jul 27	HSBC	Downgrade	Hold → Reduce	—	$8.82	$8.71	-1.2%	-0.7%	-1.1%	-1.0%	+0.9%	+0.0%
Jul 26	Credit Suisse	Downgrade	Neutral → Underweight	—	$10.42	$9.80	-6.0%	-15.4%	-15.9%	-16.3%	-16.2%	-14.6%
May 2	Goldman Sachs	Maintains	Neutral → Neutral	—	$9.12	$9.02	-1.1%	-1.5%	-2.0%	-4.8%	-5.3%	-8.1%
Feb 10	CLSA	Upgrade	Underperform → Buy	—	$8.38	$8.45	+0.8%	-0.5%	+0.8%	-0.2%	+2.1%	+6.7%
Dec 2	Deutsche Bank	Maintains	Sell → Sell	—	$9.61	$9.65	+0.4%	+0.3%	-1.6%	-1.1%	-3.1%	-9.4%
Feb 15	BofA Securities	Downgrade	Buy → Neutral	—	$6.96	$6.76	-2.9%	-2.6%	-2.7%	-3.4%	-4.9%	-4.7%
Feb 15	Bank of America	Downgrade	Buy → Neutral	—	$6.96	$6.76	-2.9%	-2.6%	-2.7%	-3.4%	-4.9%	-4.7%
Dec 12	Credit Suisse	Upgrade	Neutral → Outperform	—	$6.88	$6.90	+0.3%	-0.4%	-1.6%	-2.3%	-2.0%	-2.5%
Jun 28	Anand Rathi	Upgrade	Hold → Buy	—	$5.69	$5.65	-0.7%	-0.7%	+4.4%	+4.4%	+8.8%	+4.7%
Feb 7	Credit Suisse	Downgrade	Buy → Hold	—	$6.77	$6.66	-1.6%	-2.4%	-3.2%	-3.2%	-4.4%	-3.2%

Data updated apr 26, 2026 10:17pm · Source: massive.com